The infrastructure of the United States pharmaceutical supply chain is governed by a highly scrutinized, dual-layered enforcement matrix. Because Schedule I and Schedule II controlled substances possess the highest potential for abuse, psychological dependence, and physical addiction within clinical medicine, their distribution pathways must be tightly insulated against diversion. At the baseline of this protective […]
The handling, distribution, and dispensing of controlled substances within commercial and institutional pharmacies operate under a strict federal enforcement framework. Because chemical compounds with a high potential for abuse or dependence pose substantial systemic risks to public health and safety, their life cycle must be meticulously tracked. Far from being a mere collection of procedural […]